Genor Biopharma Holdings Statistics

Total Valuation

HKG:6998 has a market cap or net worth of HKD 1.32 billion. The enterprise value is 198.37 million.

Market Cap	1.32B
Enterprise Value	198.37M

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:6998 has 521.23 million shares outstanding. The number of shares has increased by 1.44% in one year.

Current Share Class	521.23M
Shares Outstanding	521.23M
Shares Change (YoY)	+1.44%
Shares Change (QoQ)	+1.52%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	0.34%
Float	258.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.03
PB Ratio	1.08
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.63
EV / Sales	0.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.51

Financial Position

The company has a current ratio of 8.74, with a Debt / Equity ratio of 0.00.

Current Ratio	8.74
Quick Ratio	8.74
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-302.07

Financial Efficiency

Return on equity (ROE) is -4.52% and return on invested capital (ROIC) is -1.80%.

Return on Equity (ROE)	-4.52%
Return on Assets (ROA)	-1.55%
Return on Invested Capital (ROIC)	-1.80%
Return on Capital Employed (ROCE)	-2.90%
Revenue Per Employee	9.14M
Profits Per Employee	-2.27M
Employee Count	24
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.44% in the last 52 weeks. The beta is 0.66, so HKG:6998's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+98.44%
50-Day Moving Average	2.28
200-Day Moving Average	1.86
Relative Strength Index (RSI)	53.19
Average Volume (20 Days)	1,267,850

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6998 had revenue of HKD 219.46 million and -54.57 million in losses. Loss per share was -0.11.

Revenue	219.46M
Gross Profit	218.04M
Operating Income	-36.00M
Pretax Income	-37.39M
Net Income	-54.57M
EBITDA	-18.91M
EBIT	-36.00M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 1.13 billion in cash and 969,461 in debt, giving a net cash position of 1.13 billion or 2.16 per share.

Cash & Cash Equivalents	1.13B
Total Debt	969,461
Net Cash	1.13B
Net Cash Per Share	2.16
Equity (Book Value)	1.23B
Book Value Per Share	2.37
Working Capital	1.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -129.81 million and capital expenditures -1.67 million, giving a free cash flow of -131.48 million.

Operating Cash Flow	-129.81M
Capital Expenditures	-1.67M
Free Cash Flow	-131.48M
FCF Per Share	-0.25

Full Cash Flow Statement

Margins

Gross margin is 99.35%, with operating and profit margins of -16.41% and -24.87%.

Gross Margin	99.35%
Operating Margin	-16.41%
Pretax Margin	-17.04%
Profit Margin	-24.87%
EBITDA Margin	-8.62%
EBIT Margin	-16.41%
FCF Margin	n/a

Dividends & Yields

HKG:6998 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.44%
Shareholder Yield	n/a
Earnings Yield	-4.12%
FCF Yield	-9.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:6998 has an Altman Z-Score of -3.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.77
Piotroski F-Score	n/a